跳至主要内容
临床试验/NCT01743742
NCT01743742已完成4 期

The First-day High Dose Vitamin E and Vitamin C in Hypoxic Ischemic Encephalopathy (Following Birth Asphyxia) in Newborns

Sir Takhtasinhji General Hospital1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
95
试验地点
1
主要终点
To assess the role of first day high-dose vitamin E and vitamin C in reduction of adverse neurodevelopmental sequel in newborns with birth asphyxia.

研究概览

简要总结

To study the role of first-day high dose oral vitamin C and first-day single high dose oral vitamin E in hypoxic-ischemic encephalopathy in newborns, in the reduction of morbidity and adverse neurodevelopmental sequelae.

详细描述

Design: A prospective, randomized controlled trial over 5 months. Patients: Newborns admitted within 6 hours after birth with gestation >32 weeks, Apgar score of <6 at 5 minutes, features suggestive of neonatal encephalopathy.

Intervention: After randomization, Group A newborns received oral vitamin C 250 mg once a day within a 24-hour interval along with a single dose of vitamin E 200 IU. Group B newborns received no intervention.

Outcome measures: Severity and progression of birth asphyxia, duration of hospitalization and mechanical ventilation, mortality, and neurodevelopmental outcome.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Minute 至 6 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Oral vitamin E, vitamin C

Experimental

Single dose of vitamin E drops 200 IU within 6 hours of birth and vitamin C tablet 250 mg in pulverised form (2 doses at 24 hr interval) via infant feeding tube

干预措施: Vitamin E, Vitamin C (Drug)

结局指标

主要结局

To assess the role of first day high-dose vitamin E and vitamin C in reduction of adverse neurodevelopmental sequel in newborns with birth asphyxia.

时间窗: 6 months

Vitamin C and E were initiated orally within 6 hours of birth.

次要结局

  • Mortality and morbidity in newborns with birth asphyxia administered vitamin E and vitamin C.(From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 15 DAYS.)

研究者

发起方
Sir Takhtasinhji General Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jayendra R. Gohil, MD, PROF.

Professor of Pediatrics

Sir Takhtasinhji General Hospital

研究点 (1)

Loading locations...

相似试验

First-day High Dose Vitamin C, E in Severe Birth... | 临床试验